Atalanta Sosnoff Capital Has Decreased Becton Dickinson & Co (BDX) Holding; Intercept (ICPT) Sentiment Is 1.31

Atalanta Sosnoff Capital Llc decreased Becton Dickinson & Co (BDX) stake by 1.79% reported in 2017Q4 SEC filing. Atalanta Sosnoff Capital Llc sold 3,746 shares as Becton Dickinson & Co (BDX)’s stock declined 1.94%. The Atalanta Sosnoff Capital Llc holds 205,495 shares with $43.99M value, down from 209,241 last quarter. Becton Dickinson & Co now has $56.72 billion valuation. The stock decreased 1.04% or $2.23 during the last trading session, reaching $213.02. About 1.36M shares traded. Becton, Dickinson and Company (NYSE:BDX) has risen 15.92% since March 28, 2017 and is uptrending. It has outperformed by 4.37% the S&P500.

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. The company has market cap of $1.52 billion. The Company’s lead product candidate is obeticholic acid , a bile acid analog, which has a structure based on a naturally occurring human bile acid that selectively binds to and activates the farnesoid X receptor (FXR). It currently has negative earnings. The firm is developing OCA to treat various non-viral progressive liver diseases, such as nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia.

Among 20 analysts covering Becton Dickinson (NYSE:BDX), 12 have Buy rating, 0 Sell and 8 Hold. Therefore 60% are positive. Becton Dickinson has $260.0 highest and $146 lowest target. $230.05’s average target is 7.99% above currents $213.02 stock price. Becton Dickinson had 52 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was downgraded by Evercore on Wednesday, January 6 to “Hold”. The firm has “Buy” rating by Jefferies given on Tuesday, February 6. The firm has “Hold” rating given on Monday, August 10 by Deutsche Bank. The stock of Becton, Dickinson and Company (NYSE:BDX) has “Buy” rating given on Monday, July 10 by Cowen & Co. The stock of Becton, Dickinson and Company (NYSE:BDX) has “Buy” rating given on Thursday, November 9 by Jefferies. The company was downgraded on Friday, September 23 by Citigroup. The firm earned “Buy” rating on Thursday, November 2 by Stifel Nicolaus. On Friday, June 30 the stock rating was upgraded by Raymond James to “Strong Buy”. The stock of Becton, Dickinson and Company (NYSE:BDX) has “Hold” rating given on Thursday, August 3 by RBC Capital Markets. The company was maintained on Tuesday, February 6 by Piper Jaffray.

Since February 23, 2018, it had 0 insider buys, and 4 selling transactions for $2.59 million activity. Shares for $426,079 were sold by Polen Thomas E Jr on Tuesday, March 13. $38,416 worth of Becton, Dickinson and Company (NYSE:BDX) shares were sold by RING TIMOTHY M. Shares for $1.21 million were sold by Gallagher John E. The insider Borzi James W sold 4,048 shares worth $910,726.

Atalanta Sosnoff Capital Llc increased Roper Technologies Inc (NYSE:ROP) stake by 53,464 shares to 168,294 valued at $43.59M in 2017Q4. It also upped Pnc Bank Corp (NYSE:PNC) stake by 191,476 shares and now owns 424,512 shares. Costco Whsl Corp New (NASDAQ:COST) was raised too.

Analysts await Becton, Dickinson and Company (NYSE:BDX) to report earnings on May, 1. They expect $2.60 EPS, up 13.04% or $0.30 from last year’s $2.3 per share. BDX’s profit will be $692.23M for 20.48 P/E if the $2.60 EPS becomes a reality. After $2.48 actual EPS reported by Becton, Dickinson and Company for the previous quarter, Wall Street now forecasts 4.84% EPS growth.

Investors sentiment increased to 1.55 in 2017 Q4. Its up 0.62, from 0.93 in 2017Q3. It is positive, as 50 investors sold BDX shares while 294 reduced holdings. 147 funds opened positions while 386 raised stakes. 215.77 million shares or 9.23% more from 197.53 million shares in 2017Q3 were reported. Cacti Asset Ltd Liability Corp invested 3.61% of its portfolio in Becton, Dickinson and Company (NYSE:BDX). Janney Capital Mngmt Limited Liability Company invested in 979 shares. Dekabank Deutsche Girozentrale holds 0.36% in Becton, Dickinson and Company (NYSE:BDX) or 226,674 shares. Envestnet Asset Mngmt Inc reported 0.04% of its portfolio in Becton, Dickinson and Company (NYSE:BDX). Private Advisor Grp Limited Company has 8,750 shares. Puzo Michael J reported 1,000 shares. Blair William Co Il has invested 0.08% in Becton, Dickinson and Company (NYSE:BDX). Finemark Fincl Bank And has 0.03% invested in Becton, Dickinson and Company (NYSE:BDX) for 2,519 shares. Dearborn Prtnrs Ltd Liability Corp invested 2.84% of its portfolio in Becton, Dickinson and Company (NYSE:BDX). First Tru Lp has invested 0% in Becton, Dickinson and Company (NYSE:BDX). Davis R M Incorporated owns 8,490 shares. Hugh Johnson Advisors Limited Co stated it has 2,632 shares or 0.16% of all its holdings. Natl Bank Of New York Mellon Corporation holds 0.11% of its portfolio in Becton, Dickinson and Company (NYSE:BDX) for 2.01 million shares. Taurus Asset Mgmt Limited Liability Corporation invested 1.62% of its portfolio in Becton, Dickinson and Company (NYSE:BDX). North Carolina-based Atria Ltd Company has invested 0.02% in Becton, Dickinson and Company (NYSE:BDX).

The stock decreased 3.48% or $2.18 during the last trading session, reaching $60.52. About 558,612 shares traded. Intercept Pharmaceuticals, Inc. (ICPT) has declined 48.35% since March 28, 2017 and is downtrending. It has underperformed by 59.90% the S&P500.

Sarissa Capital Management Lp holds 2.73% of its portfolio in Intercept Pharmaceuticals, Inc. for 182,300 shares. Bb Biotech Ag owns 485,719 shares or 0.8% of their US portfolio. Moreover, Altrinsic Global Advisors Llc has 0.7% invested in the company for 310,300 shares. The New York-based Spark Investment Management Llc has invested 0.57% in the stock. Regal Investment Advisors Llc, a Michigan-based fund reported 30,147 shares.